Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 71,642 | 66,966 | 65,692 | 66,117 | 59,366 |
| Cost of Goods | 10,140 | 6,942 | 5,354 | 4,818 | N/A |
| Gross Profit | 61,502 | 60,024 | 60,338 | 61,299 | 59,366 |
| Operating Expenses | 46,784 | 42,510 | 63,292 | 38,861 | 36,232 |
| Operating Income | 14,858 | 18,456 | -2,600 | 23,256 | 23,134 |
| Interest Expense | 10,591 | 10,042 | 9,479 | 8,967 | 9,047 |
| Other Income | -192 | -130 | -121 | -2 | -100 |
| Pre-tax Income | 4,075 | 8,284 | -12,200 | 14,287 | 13,987 |
| Income Tax | 361 | 1,133 | 581 | 1,272 | 1,057 |
| Net Income Continuous | 3,714 | 7,151 | -12,781 | 13,015 | 12,930 |
| Minority Interests | 3 | 34 | 38 | 26 | 41 |
| Net Income | $3,711 | $7,117 | $-12,819 | $12,989 | $12,889 |
| EPS Basic Total Ops | 0.19 | 0.36 | -0.60 | 0.62 | 0.61 |
| EPS Basic Continuous Ops | 0.19 | 0.36 | -0.60 | 0.62 | 0.61 |
| EPS Diluted Total Ops | 0.19 | 0.36 | -0.59 | 0.62 | 0.60 |
| EPS Diluted Continuous Ops | 0.19 | 0.36 | -0.59 | 0.62 | 0.60 |
| EBITDA(a) | $40,423 | $42,399 | $46,210 | $46,691 | $45,961 |